
Zensure Pharma LLP
About Zensure Pharma LLP
Data last updated:
Zensure Pharma LLP is a limited liability partnership (LLP) based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 February 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Pune, under LLPIN AAF-7099. Its GSTIN is 27AABFZ5750H1ZX (Maharashtra).
The LLP has a total obligation of contribution of ₹10 Lakh. It is led by designated partners including Manjoosha Rajendra Kale and Smita Sonje Sandeep.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Flat No D – 401 Yashraj Avenue Bhekrai Nagar S.No. 177 H.No 26 27 Phursungi, Pune, Maharashtra, India – 412308.
As per the financials filed for FY 2021, the LLP reported a revenue of ₹56.05 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹3.31 Lakh (net margin 5.9%) and EBITDA of ₹56.67 Lakh (EBITDA margin 101.1%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat No D – 401 Yashraj Avenue Bhekrai Nagar S.No. 177 H.No 26 27 Phursungi, Pune, Maharashtra, India – 412308
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Zensure Pharma LLP FY 2025 filings available
Zensure Pharma LLP reported revenue of ₹56.05 Lakh (down 12% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of Zensure Pharma LLP
Revenue fell 12% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 21%. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Zensure Pharma LLP
| Statement of Account and Solvency | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | ₹56.05 Lakh | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | ₹3.31 Lakh | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Zensure Pharma LLP
| Statement of Account and Solvency | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 5.9% | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Zensure Pharma are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Zensure Pharma LLP
Zensure Pharma LLP is audited by P R A S S & ASSOCIATES LLP for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| P R A S S & ASSOCIATES LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Designated Partners of Zensure Pharma LLP
Zensure Pharma has 6 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manjoosha Rajendra Kale | Designated Partner | 14 Feb 2016 | 10 Years 7 Months | Current |
| Smita Sonje Sandeep | Designated Partner | 14 Feb 2016 | 10 Years 7 Months | Current |
| Manjusha Ganesh Patil | Designated Partner | 14 Feb 2016 | 10 Years 7 Months | Current |
| Surekha Bhika Patil | Designated Partner | 14 Feb 2016 | 10 Years 7 Months | Current |
| Usha Rajendra Salunke | Designated Partner | 14 Feb 2016 | 10 Years 7 Months | Current |
| Swati Jagtap Govindrao | Designated Partner | 14 Feb 2016 | 10 Years 7 Months | Current |
Ownership and Shareholding of Zensure Pharma LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Zensure Pharma LLP
Zensure Pharma LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Zensure Pharma LLP
Employment history and EPFO contributions of people linked to Zensure Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Zensure Pharma LLP
Zensure Pharma LLP has 6 designated partner changes on record since 2016: 6 appointments. The latest: Manjoosha Rajendra Kale was appointed as Designated Partner on 14 Feb 2016.
Credit Ratings, Litigation & Regulatory Alerts for Zensure Pharma LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Zensure Pharma LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Zensure Pharma LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Zensure Pharma LLP
Zensure Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABFZ5750H1ZX | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Zensure Pharma LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zensure Pharma LLP
Zensure Pharma is an active limited liability partnership based in Pune, Maharashtra, India. The LLP works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 February 2016 (10+ years old) and is registered under LLPIN AAF-7099.
Zensure Pharma reported revenue of ₹56.05 Lakh for FY 2021 (down 12% YoY).
Zensure Pharma has 6 current designated partners:
- Manjoosha Rajendra Kale - Designated Partner
- Smita Sonje Sandeep - Designated Partner
- Manjusha Ganesh Patil - Designated Partner
- Surekha Bhika Patil - Designated Partner
- Usha Rajendra Salunke - Designated Partner
- Swati Jagtap Govindrao - Designated Partner
Zensure Pharma reported a net profit of ₹3.31 Lakh (net margin 5.9%) and EBITDA of ₹56.67 Lakh (EBITDA margin 101.1%) for FY 2021, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Zensure Pharma is 21% over three years. In the latest year (FY 2021) revenue fell 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Zensure Pharma is 27AABFZ5750H1ZX, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Zensure Pharma is AAF-7099. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Zensure Pharma was incorporated on 14 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Pune.
Manjoosha Rajendra Kale was appointed as Designated Partner on 14 Feb 2016. Manjusha Ganesh Patil was appointed as Designated Partner on 14 Feb 2016. Smita Sonje Sandeep was appointed as Designated Partner on 14 Feb 2016. Zensure Pharma has 6 designated partner changes on record in total.
The registered office of Zensure Pharma is at Flat No D – 401 Yashraj Avenue Bhekrai Nagar S.No. 177 H.No 26 27 Phursungi, Pune, Maharashtra, India – 412308.